NCT00060489已完成3 期
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 试验地点
- 27
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written Informed Consent;
- •Bipolar disorder with most recent episode depressed;
- •Outpatient status
排除标准
- •Patients with a current Axis I disorder other than bipolar disorder within 6 months of screening;
- •Patients whose current episode of depression exceeds 12 months or is less than 4 weeks
研究者
研究点 (27)
Loading locations...
相似试验
已完成
4 期
Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GADBipolar DisorderGeneralized Anxiety DisorderPanic DisorderNCT00579280University of South Florida224
已完成
2 期
Quetiapine in Social Anxiety DisorderSocial Anxiety DisorderNCT00215254Duke University15
已完成
3 期
Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic SymptomsBipolar DisorderNCT00277667Lindner Center of HOPE40
已完成
3 期
A Study of Quetiapine for the Treatment of Mood Disorders in AdolescentsMood DisordersNCT00221468University of Cincinnati20
已完成
3 期
Seroquel in Bipolar Depression Versus SSRIBipolar DisorderBipolar DepressionDepressionNCT00119652AstraZeneca676